December 15, 2009
DUBLIN--(BUSINESSWIRE)--ResearchandMarkets(http://www.researchandmarkets.com/research/0057b4/the_future_of_cont) has announced the addition of the "The Future of Contract Manufacturing - Market Forecasts to 2015 and Key Trends" report to their offering.
"The Future of Contract Manufacturing - Market Forecasts to 2015 and Key Trends" provides an essential source of data and analysis on the global CMO market with coverage on the market landscape, key market trends, market drivers and restraints. The report identifies the key trends shaping and driving the dynamism in the global CMO market. The report also provides an insight in to the prevalent competitive landscape with key company profiles.
The Global CMO Market is Forecast to Show Steady Growth over the Forecast Period
The report suggests that the global contract manufacturing outsourcing (CMO) market set to grow steadily due to increased outsourcing of Pharmaceutical production for Western Pharmaceutical manufacturers to Asian Countries. The global CMO market was valued at $21 billion in 2008. This market grew at around 9.5% over 2007 when the market was approximately $19.5 billion. The major factor driving this market is the increase in the sourcing of biologics and generic manufacturing. The market revenues are forecast to reach approximate value of $44 billion by 2015. The market is forecast to grow at a CAGR of 11%.
CMOs Have Started Providing End-to-End Solutions for Pharmaceutical Manufacturers Expanding Market Potential
Earlier CMOs restricted their businesses only to the key production aspects of the pharmaceutical production chain. This was because Pharma manufacturers seldom approached CMOs for services other than primary and secondary manufacturing.
CMO Market, Global, CMOs Providing Overall Pharmaceutical Solutions, 2008
Presently the CMO market is witnessing stiff competition with numerous CMOs emerging within a short time span. In order to remain dominant within the market, Tier 1 CMOs have started offering complete Pharma solutions to clients. This implies that these CMOs assist Pharma manufacturer's right from clinical trials to commercial manufacturing, logistics, packaging, and even marketing assistance. Subsequently Pharma manufacturers seem to increasingly accept this business model and are increasingly outsourcing their production in an effort to save cost and continue production.
Initially this concept of providing total Pharma solutions was present only within the US and certain European countries. Over the past couple of years countries like India, Korea and China have started adopting the same business model. Due to vast difference is the production and labor costs, Manufacturers are shifting their focus to Asian CMOs. It is seen that overall costs for drug manufacturing in India for example, is up to 50% cheaper than in Western countries. Cost savings in this scale present a golden opportunity for Western Pharma manufacturers to outsource to Asian CMOs. Apart from this CMOs are also applying the strategy of integration. Over the past couple of years CMOs are integrating their service portfolios to offer complete solutions to Pharma manufacturers. Through these kinds of relationships, both the CMOs can pursue large-scale business opportunities using each others' facilities.
SOURCE: BUSINESSWIRE
[ Back to top ]